Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Fuji
Baxter
Boehringer Ingelheim
Fish and Richardson
Daiichi Sankyo
Johnson and Johnson
UBS
US Army
Express Scripts

Generated: January 22, 2018

DrugPatentWatch Database Preview

NEUPRO Drug Profile

« Back to Dashboard

Which patents cover Neupro, and when can generic versions of Neupro launch?

Neupro is a drug marketed by Ucb Inc and is included in one NDA. There are six patents protecting this drug and one Paragraph IV challenge.

This drug has one hundred and twenty-seven patent family members in thirty-two countries.

The generic ingredient in NEUPRO is rotigotine. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the rotigotine profile page.

US Patents and Regulatory Information for NEUPRO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc NEUPRO rotigotine FILM, EXTENDED RELEASE;TRANSDERMAL 021829-006 Apr 2, 2012 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ucb Inc NEUPRO rotigotine FILM, EXTENDED RELEASE;TRANSDERMAL 021829-003 May 9, 2007 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ucb Inc NEUPRO rotigotine FILM, EXTENDED RELEASE;TRANSDERMAL 021829-003 May 9, 2007 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ucb Inc NEUPRO rotigotine FILM, EXTENDED RELEASE;TRANSDERMAL 021829-003 May 9, 2007 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ucb Inc NEUPRO rotigotine FILM, EXTENDED RELEASE;TRANSDERMAL 021829-004 Apr 2, 2012 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ucb Inc NEUPRO rotigotine FILM, EXTENDED RELEASE;TRANSDERMAL 021829-005 Apr 2, 2012 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ucb Inc NEUPRO rotigotine FILM, EXTENDED RELEASE;TRANSDERMAL 021829-002 May 9, 2007 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ucb Inc NEUPRO rotigotine FILM, EXTENDED RELEASE;TRANSDERMAL 021829-006 Apr 2, 2012 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ucb Inc NEUPRO rotigotine FILM, EXTENDED RELEASE;TRANSDERMAL 021829-006 Apr 2, 2012 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ucb Inc NEUPRO rotigotine FILM, EXTENDED RELEASE;TRANSDERMAL 021829-004 Apr 2, 2012 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for NEUPRO
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Extended-release Transdermal Film 1 mg/24 hr, 2 mg/24 hr, 3 mg/24 hr,4 mg/24 hr,6 mg/24 hr, and 8 mg/24 hr ➤ Subscribe 11/26/2013

International Patents for NEUPRO

Supplementary Protection Certificates for NEUPRO

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB06/023 United Kingdom ➤ Subscribe SPC/GB06/023: 20070702, EXPIRES: 20210214
C026/2006 Ireland ➤ Subscribe SPC026/2006:, EXPIRES: 20210214
24/2006 Austria ➤ Subscribe PRODUCT NAME: ROTIGOTINE
C0025 France ➤ Subscribe PRODUCT NAME: ROTIGOTINE; REGISTRATION NO/DATE: EU/1/05/331/001 20060215
2006 00020 Denmark ➤ Subscribe PRODUCT NAME: ROTIGOTINE
/2006 Austria ➤ Subscribe PRODUCT NAME: ROTIGOTINE; REGISTRATION NO/DATE: EU/1/05/331/001 - EU/1/05/331/013 20060215
269 Luxembourg ➤ Subscribe 91269, EXPIRES: 20210215
1033978/01 Switzerland ➤ Subscribe PRODUCT NAME: ROTIGOTINE; REGISTRATION NUMBER/DATE: SWISSMEDIC 57417 27.09.2006
00236 Netherlands ➤ Subscribe PRODUCT NAME: ROTIGOTINE; REGISTRATION NO/DATE: EU/1/05/331/001-013 20060215
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Farmers Insurance
Julphar
Healthtrust
Baxter
Accenture
QuintilesIMS
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot